نتایج جستجو برای: brca1

تعداد نتایج: 8182  

Journal: :Molecular and cellular biology 2001
L J Huber T W Yang C J Sarkisian S R Master C X Deng L A Chodosh

Both human and mouse cells express an alternatively spliced variant of BRCA1, BRCA1-Delta11, which lacks exon 11 in its entirety, including putative nuclear localization signals. Consistent with this, BRCA1-Delta11 has been reported to reside in the cytoplasm, a localization that would ostensibly preclude it from playing a role in the nuclear processes in which its full-length counterpart has b...

2012
Jos Jonkers

Author’s Affi liation: Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding Author: Jos Jonkers, Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Phone: 31-20-5122000; Fax: 31-20-5122050; E-mail: [email protected] doi: 10.1158/2159-8290.CD-12-0186 ©2012 American Associati...

2016
Angel Chao Ting-Chang Chang Nina Lapke Shih-Ming Jung Peter Chi Chien-Hung Chen Lan-Yan Yang Cheng-Tao Lin Huei-Jean Huang Hung-Hsueh Chou Jui-Der Liou Shu-Jen Chen Tzu-Hao Wang Chyong-Huey Lai

Germline and somatic BRCA1/2 mutations define a subset of patients with ovarian cancer who may benefit from treatment with poly (ADP-ribose) polymerase inhibitors. Unfortunately, data on the frequency of BRCA1/2 germline mutations in Taiwanese patients with ovarian cancer are scarce, with the prevalence of somatic mutations being unknown. We aim to investigate the occurrence of BRCA1/2 mutation...

Journal: :Cancer research 2002
Lodewyk F A Wessels Tibor van Welsem Augustinus A M Hart Laura J van't Veer Marcel J T Reinders Petra M Nederlof

In approximately 70% of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or BRCA2 germline mutations cannot be identified with the current screening regime. Therefore, we used data mining to identify a somatic genetic signature to differentiate BRCA1 mutation carriers from non-BRCA1 carriers based on the genetic characteristics of their breast carcinomas. Fo...

Journal: :Journal of medical genetics 2012
Amanda B Spurdle Phillip J Whiley Bryony Thompson Bingjian Feng Sue Healey Melissa A Brown Christopher Pettigrew Christi J Van Asperen Margreet G E M Ausems Anna A Kattentidt-Mouravieva Ans M W van den Ouweland Annika Lindblom Maritta H Pigg Rita K Schmutzler Christoph Engel Alfons Meindl Sandrine Caputo Olga M Sinilnikova Rosette Lidereau Fergus J Couch Lucia Guidugli Thomas van Overeem Hansen Mads Thomassen Diana M Eccles Kathy Tucker Javier Benitez Susan M Domchek Amanda E Toland Elizabeth J Van Rensburg Barbara Wappenschmidt Åke Borg Maaike P G Vreeswijk David E Goldgar

BACKGROUND Clinical classification of rare sequence changes identified in the breast cancer susceptibility genes BRCA1 and BRCA2 is essential for appropriate genetic counselling of individuals carrying these variants. We previously showed that variant BRCA1 c.5096G>A p.Arg1699Gln in the BRCA1 transcriptional transactivation domain demonstrated equivocal results from a series of functional assay...

2010
Brian J. Kluk Yebo Fu Trina A. Formolo Lei Zhang Anne K. Hindle Yan-gao Man Robert S. Siegel Patricia E. Berg Chuxia Deng Timothy A. McCaffrey Sidney W. Fu

INTRODUCTION Several lines of evidence point to an important role for BP1, an isoform of DLX4 homeobox gene, in breast carcinogenesis and progression. BRCA1 is a well-known player in the etiology of breast cancer. While familial breast cancer is often marked by BRCA1 mutation and subsequent loss of heterozygosity, sporadic breast cancers exhibit reduced expression of wild type BRCA1, and loss o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
K Yoshikawa K Honda T Inamoto H Shinohara A Yamauchi K Suga T Okuyama T Shimada H Kodama S Noguchi A F Gazdar Y Yamaoka R Takahashi

BRCA1 is a tumor suppressor gene that is responsible for hereditary breast and ovarian cancer syndrome. To clarify the possible involvement of the BRCA1 protein in mammary carcinogenesis in sporadic and hereditary forms, we have analyzed the BRCA1 protein expression pattern in five breast epithelial cell lines, including a BRCA1-deficient cell line, and 162 breast cancer tissue samples [includi...

2013
Aya Masaoka Natalie R. Gassman Julie K. Horton Padmini S. Kedar Kristine L. Witt Cheryl A. Hobbs Grace E. Kissling Keizo Tano Kenjiro Asagoshi Samuel H. Wilson

The breast cancer 1 (BRCA1) protein is a tumor suppressor playing roles in DNA repair and cell cycle regulation. Studies of DNA repair functions of BRCA1 have focused on double-strand break (DSB) repair pathways and have recently included base excision repair (BER). However, the function of BRCA1 in BER is not well defined. Here, we examined a BRCA1 role in BER, first in relation to alkylating ...

Journal: :Molecular and cellular biology 2010
Foon Wu-Baer Thomas Ludwig Richard Baer

Although the BRCA1 tumor suppressor has been implicated in many cellular processes, the biochemical mechanisms by which it influences these diverse pathways are poorly understood. The only known enzymatic function of BRCA1 is the E3 ubiquitin ligase activity mediated by its highly conserved RING domain. In vivo, BRCA1 associates with the BARD1 polypeptide to form a heterodimeric BRCA1/BARD1 com...

Journal: :The EMBO journal 2006
Liu Cao Sangsoo Kim Cuiying Xiao Rui-Hong Wang Xavier Coumoul Xiaoyan Wang Wen Mei Li Xiao Ling Xu Joseph A De Soto Hiroyuki Takai Sabine Mai Stephen J Elledge Noboru Motoyama Chu-Xia Deng

BRCA1 is a checkpoint and DNA damage repair gene that secures genome integrity. We have previously shown that mice lacking full-length Brca1 (Brca1(delta11/delta11)) die during embryonic development. Haploid loss of p53 completely rescues embryonic lethality, and adult Brca1(delta11/delta11)p53+/- mice display cancer susceptibility and premature aging. Here, we show that reduced expression and/...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید